Renaissance Capital logo

Dermira Priced, Nasdaq: DERM.XX

Biotech targeting skin conditions such as psoriasis, excessive sweating and acne.

Industry: Health Care

First Day Return: -2.8%

Biotech targeting skin conditions such as psoriasis, excessive sweating and acne.

Dermira (DERM.XX) Performance

Created with Highcharts 10.3.2Chart context menuDERM.XX vs. IPO Index (IPOUSA)20152016201720182019202020212022202320242025-100%0%+ 100%+ 200%+ 300%View 5 days5dView 1 month1mView 3 months3mView year to dateYTDView 1 year1yView allAllRenaissance IPO IndexOur ETF tracks the IPO Index